Rutamarin
CAS: 13164-05-1
Ref. 3D-NAA16405
1mg | 436.00 € | ||
2mg | 621.00 € | ||
5mg | 1,044.00 € | ||
10mg | 1,739.00 € | ||
25mg | 3,913.00 € |
Product Information
- (+)-Rutamarin
- (2S)-2-[1-(Acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one
- 7H-Furo[3,2-g][1]benzopyran-7-one, 2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, acetate
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,acetate (8CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-(9CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (S)-
- Chalepin acetate
- NSC 263654
- S-(+)-Chalepin acetate
- See more synonyms
Rutamarin is a low molecular weight inhibitor with a molecular weight of 567. It binds to the ATP binding site of the mitochondrial membrane, thereby inhibiting its function. Rutamarin inhibits the production of inflammatory mediators in vitro and in vivo by inhibiting cyclooxygenase-2 (COX-2) and the COX-2-dependent synthesis of prostaglandins. Rutamarin also causes a reduction in colorectal adenocarcinoma cells, as well as metabolic profiles that are associated with carcinomas. This drug also affects fatty acid metabolism, which may be due to its inhibition of peroxisome proliferator activated receptor (PPAR).
Chemical properties
Technical inquiry about: 3D-NAA16405 Rutamarin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.